INSIGHTS ON PHARMACEUTICAL LOGISTICS

• Pharmaceutical Cold Chain Expertise — A Missing CMDO Ingredient?

  What if CMOs/CMDOs could offer a true end-to-end solution by ensuring strict temperature control of their products in transit? What impact would these solutions have on pharma customers?

• Cold Chain Qualification: 5 Questions You Must Ask When Shipping Biologics

  Organizations recognize the growing need for control of the entire cold chain as the changing global scenario requires highly efficient processes and flexibility.

• Validating The Stability And Durability Of Labels After Thawing From Cryogenic Temperatures

  One important element of working in cryogenic temperatures involves ensuring labels remain intact and securely adhered to packaging after application as product moves from ambient temperatures to cryogenic temperatures to thawing at the point of use. The following study serves as a model for the need to validate label stability and adherence and is an example of the many different types of validation studies we regularly conduct to mitigate risk for customers during all phases of an advanced therapy clinical trial.

• Global Air Cargo Trends Re-Shaping Pharmaceutical Transport

  As we welcome the new decade and the exciting advances it is expected to unleash, many of the forces that shaped the past decade for transporting pharmaceuticals will continue. Price pressures, alternatives to air freight and increasing automation are just a few. However, there are emerging trends that make 2020 unique. As we look forward, these are the air cargo trends expected to shape the transport of pharmaceuticals in 2020 and beyond.

• Container Closure Integrity Testing For Sterile Vial Products In Deep Cold Storage

  A vaccine-focused biotechnology company approached LIGHTHOUSE to help investigate a phenomenon observed in liquid vaccine product stored at -80°C. During QC testing, a number of vials were found to have an overpressure. This phenomenon represented a serious safety risk and LIGHTHOUSE was asked to support an investigation to identify the root cause.

• Comparing Carbon Footprints Of Similar Single-Use Shippers

  It is important for organizations to carefully consider the impact of their containment, packaging, and shipping decisions, especially when high volumes of transactions are involved.

• Managing Clinical Ancillary Supplies At Global Scale

  Clinical ancillary management expertise helps biopharma company oversee a large, global trial from start through finish.

• The Importance Of Inventory Management: Do You Know Where Your Samples Are?

  With the exciting advances in research and drug development, the importance of sample management has never been higher. If you have ever experienced sample management mishaps, we ask: Do you know where your samples are? In this article, we’ll explore some of the common causes of inventory mismanagement and best practices to guard against sample loss and near misses.

• Quick To Clinic™ for Oral Solid Dose

  In as little as 14 weeks from receiving your small molecule API, you can have your Phase I drug product manufactured, labelled, packaged and delivered to the clinic. That’s 1 month faster than most standard timelines, and includes a one-month stability study.